ReviewJournal of translational medicine2026
Advances in near-infrared fluorescent probes for the tumor microenvironment.
Review in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCancer remains a major threat to human health worldwide, but with progress in early diagnosis and treatment technology, the progression of cancer has been effectively slowed. Near-infrared (NIR) fluorescent probes are noninvasive imaging tools that show great promise for early tumor detection and intra-operative guidance due to their high sensitivity, deep tissue penetration, and high signal-to-noise ratio. MAIN BODY: In recent years, the rapid development of NIR fluorescent probes has been driven by a growing understanding of the unique characteristics of the tumor microenvironment. Targeting these features, such as pH, viscosity, polarity, hypoxia, and enzymes, has become a key strategy in the rational design of sensitive small-molecule fluorescent probes for cancer diagnosis and therapy. In this review, we have summarized the recent progress in NIR fluorescent probes for the tumor microenvironment, with an emphasis on their design principles, imaging performance, potential applications, and the challenges faced in clinical translation.
conclusionsDespite certain progress in near-infrared fluorescent probes, challenges remain, such as tumor heterogeneity and clinical translation. Future efforts should focus on multi-responsive designs, improved photostability, and multimodal imaging strategies. We hope this review can provide a valuable reference for the development of novel fluorescent probes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.